A securities class action against Dun & Bradstreet alleges that the 2025 merger proxy misled shareholders about the company's true value and undisclosed executive conflicts, with a lead plaintiff deadline set for November 10, 2026.
A securities class action over the August 26, 2025 $9.15 per share Clearlake merger alleges the proxy misled investors on the company's true value and the Executive Chairman's conflicts. Since the merger closed in August 2025, the public shares at issue are largely gone, so the notice mainly matters to former holders; it adds reputational rather than tradable-price pressure.
Yes - investors who sold shares between May 13, 2025 and August 26, 2025, exchanged shares into the $9.15 per share merger, or held shares on the May 9, 2025 record date can seek to be lead plaintiff by November 10, 2026, or remain absent class members.
The merger closed on August 26, 2025 at $9.15 per share, so there is little public float left to trade; the immediate price impact is minimal, though litigation outcomes could matter for any residual claims.
Investors in Dun & Bradstreet Holdings, Inc. have until November 10, 2026, to seek lead plaintiff status in a securities class action lawsuit. The litigation alleges that the company's proxy statement for its $9.15 per share merger with Clearlake Capital contained misleading omissions regarding valuation and executive conflicts of interest.
Yes, investors who sold shares between May 13, 2025, and August 26, 2025, exchanged shares in the merger, or held shares on the May 9, 2025, record date may seek to be lead plaintiff by November 10, 2026.
Because the merger closed on August 26, 2025, the company is now private, meaning there is no active public float to trade; the litigation primarily concerns potential recovery for former shareholders.